1.
Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of <em>Helicobacter pylori</em> in Turkey: a nationally-representative, cross-sectional, screening with the ¹³C-urea breath test. <em>BMC Public Health.</em> 2013;13:1215. doi: 10.1186/1471-2458-13-1215
2.
Lee YC, Chiang TH, Chou CK, et al. Association between <em>Helicobacter pylori</em> eradication and gastric cancer incidence: a systematic review and meta-analysis. <em>Gastroenterology.</em> 2016; 150(5):1113-1124. doi: 10.1053/j.gastro.2016.01.028
3.
Kaplan M, Tanoglu A, Duzenli T, Tozun AN. <em>Helicobacter pylori</em> treatment in Turkey: current status and rational treatment options. <em>North Clin Istanb.</em> 2019;7(1):87-94. doi: 10.14744/nci. 2019.62558
4.
Georgopoulos SD, Xirouchakis E, Martinez Gonzalez B, et al. Clinical evaluation of a ten day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of <em>Helicobacter pylori</em> in a high clarithromycin resistance area. <em>Helicobacter</em>. 2013;18(6):459-467. doi.org/10. 1111/hel.12062
5.
Sánchez B, Delgado S, Blanco Míguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. <em>Mol Nutr Food Res</em>. 2017;61(1):1600240. doi: 10.1002/mnfr.201600240
6.
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of <em>Helicobacter pylori</em> infection<em>. Am J Gastroenterol.</em> 2017;112(2):212-239. doi: 10.1038/ajg.2016.563
7.
Wilhelm SM, Johnson JL, Kale-Pradhan PB. Treating bugs with bugs: the role of probiotics as adjunctive therapy for <em>Helicobacter pylori</em>. <em>Ann Pharmacother.</em> 2011;45(7-8):960-966. doi.org/10. 1345/aph.1Q10
8.
Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. <em>Gut.</em> 2016;65(11):1906-1915. doi.org/10.1136/gutjnl-2016-312297
9.
Lu C, Sang J, He H, et al. Probiotic supplementation does not improve eradication rate of <em>Helicobacter pylori</em> infection compared to placebo based on standard therapy: a meta-analysis. <em>Scientific Reports.</em> 2016;6(1):23522. doi: 10.1038/srep23522
10.
Oh B, Kim BS, Kim JW, et al. The effect of probiotics on gut microbiota during the <em>Helicobacter pylori</em> eradication: randomized controlled trial. <em>Helicobacter</em>. 2016;21(3):165-174. doi: 10.1111/hel.12270
11.
Demir E, Kılıç GB, Özbalcı D. Probiyotiklerin biyogüvenilirlik özellikleri “Probiyotikler”. <em>J Sci Food Agric.</em> 2019;7(4):639-645. doi:10.24925/turjaf.v7i4.639-645.2327
12.
Çekin AH, Şahintürk Y, Akbay Harmandar F, Uyar S, Yolcular BO, Çekin Y. Use of probiotics as an adjuvant to sequential <em>H. pylori</em> eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance. <em>Turk J Gastroenterol.</em> 2017;28(1):3-11. doi: 10.5152/tjg.2016.0278
13.
Özden A, Seven G, Bektaş M. Effectiveness of different treatment regimens in <em>Helicobacter pylori</em> eradication: ten year experience of a single institution. <em>Turk J Gastroenterol. </em>2010;21(3):218-223. doi: 10.4318/tjg.2010.0091
14.
Malfertheiner P, Megraud F, O’Morain C, et al. Management of <em>Helicobacter pylori</em> infection-the Maastricht V/Florence consensus report. <em>Gut.</em> 2017;66(1):6-30. doi: 10.1136/gutjnl-2016- 312288
15.
Ismail NI, Nawawi KN, Hsin DC, et al. Probiotic containing <em>Lactobacillus reuteri</em> DSM 17648 as an adjunct treatment for <em>Helicobacter</em> <em>pylori </em>infection: a randomized, double blind, placebo controlled trial. <em>Helicobacter</em>. 2023;28(6):e13017. doi: 10.1111/hel.13017
16.
Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of <em>Helicobacter pylori</em>: what should be the gold standard? <em>World J Gastroenterol.</em> 2014;20(36):12847. doi: 10.3748/wjg.v20.i36.12847
17.
Çağlar R. <em>Helicobacter pylori</em> eradikasyonunda kullanılan kombine tedavilerin etkinliklerinin karşılaştırılması. <em>SABD.</em> 2023;13(1):119-122. doi.org/10.33631/sabd.1210607
18.
Nyssen OP, Perez-Aisa A, Tepes B, et al. Adverse event profile during the treatment of <em>Helicobacter pylori</em>: a real-world experience of 22,000 patients from the European registry on <em>Helicobacter pylori</em> management (Hp-EuReg). <em>Am J Gastroenterol.</em> 2021;116(6):1220-9. doi: 10.14309/ajg.0000000000001246
19.
Viazis N, Argyriou K, Kotzampassi K, et al. A four-probiotics regimen combined with a standard <em>Helicobacter pylori</em>-eradication treatment reduces side effects and increases eradication rates. <em>Nutrients.</em> 2022;14(3):632. doi.org/10.3390/nu14030632
20.
Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H. Inhibition of binding of <em>Helicobacter pylori</em> to the glycolipid receptors by probiotic <em>Lactobacillus reuteri</em>. <em>FEMS Microbiol Rev.</em> 2002;32(2):105-110. doi.org/10.1111/j.1574-695X.2002.tb00541.x
21.
Kafshdooz T, Akbarzadeh A, Seghinsara AM, Nasrabadi HT, Milani M. Role of probiotics in managing of <em>Helicobacter pylori</em> infection: a review. <em>Drug Research</em>. 2017;11(02):88-93. doi: 10.1055/s-0042-116441
22.
Shi X, Zhang J, Mo L, Shi J, Qin M, Huang X. Efficacy and safety of probiotics in eradicating <em>Helicobacter pylori:</em> a network meta-analysis. <em>Medicine.</em> 2019;98(15):e15180. doi: 10.1097/MD. 0000000000015180
23.
Akcam M, Koca T, Salman H, Karahan N. The effects of probiotics on treatment of <em>Helicobacter pylori</em> eradication in children. <em>Saudi Med J.</em> 2015;36(3):286-290. doi: 10.15537/smj. 2015.3.10124
24.
McNicholl AG, Molina-Infante J, Lucendo AJ, et el. Probiotic supplementation with <em>Lactobacillus plantarum</em> and <em>Pediococcus acidilactici</em> for <em>Helicobacter pylori</em> therapy: a randomized, double-blind, placebo-controlled trial. <em>Helicobacter</em>. 2018;23(5):12529. doi: 10.1111/hel.12529
25.
Goderska K, Agudo Pena S, Alarcon T. <em>Helicobacter pylori</em> treatment: antibiotics or probiotics. <em>Appl Microbiol Biotechnol</em>. 2018;102:1-7. doi: 10.1007/s00253-017-8535-7